Hemocompatible and biocompatible hybrid nanocarriers for enhanced oral bioavailability of paclitaxel: in vivo evaluation.

MLA

Majeed, Asma, et al. “Hemocompatible and Biocompatible Hybrid Nanocarriers for Enhanced Oral Bioavailability of Paclitaxel: In Vivo Evaluation.” Colloids and Surfaces. B, Biointerfaces, vol. 242, Oct. 2024, p. 114073. EBSCOhost, https://doi.org/10.1016/j.colsurfb.2024.114073.

APA

Majeed, A., Akhtar, M., Khan, M., Ijaz, M., Hussain, P., Maqbool, T., & Hanan, H. (2024). Hemocompatible and biocompatible hybrid nanocarriers for enhanced oral bioavailability of paclitaxel: in vivo evaluation. Colloids and Surfaces. B, Biointerfaces, 242, 114073. https://doi.org/10.1016/j.colsurfb.2024.114073

Chicago

Majeed, Asma, Muhammad Akhtar, Mehran Khan, Muhammad Ijaz, Pakeeza Hussain, Tahir Maqbool, and Hanasul Hanan. 2024. “Hemocompatible and Biocompatible Hybrid Nanocarriers for Enhanced Oral Bioavailability of Paclitaxel: In Vivo Evaluation.” Colloids and Surfaces. B, Biointerfaces 242 (October): 114073. doi:10.1016/j.colsurfb.2024.114073.